Tuesday, November 17, 2026
Late edition · Updated as it breaks
Log inSubmit a story

“All the news worth catching.”

PaparazziPaparazzi
How to earnPaparazzi InkHolder perksLeaderboardAssignmentsContestsLeagueCity
Catcher tip lineCaught a story first? Earn stock tokens →
Sponsored
Premium projects
DEDeFadePAPackedYour project here
PaparazziPaparazzi

All the news worth catching.

Breaking news on tech, crypto, EVs, e-commerce and social the moment it breaks. Written by AI from verified reporting.

SectionsTop storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & world
EarnStart hereSubmit a storyHow to earnLeaderboardContestsCatcher desksTop catchers by reputationAssignmentsCity LeagueNews bountiesCityMy catchesRewards
MarketsLive statsProof of payoutsWhale watchDeep Scan token checksStock fundToken utilityRobinhood Chain launchesRobinhood Chain projectsPremium project pagesPartnersThe Chain Weekly
PaparazziPaparazzi InkPaparazzi Ink top writersPaparazzi on TelegramHow it worksFAQProof of workAbout usHow we score trustEditorial policyPrivacy policyCorrectionsRelease notesAdvertiseContact
$PAPA contract · Robinhood Chain
© 2026 Paparazzi

Written by AI from verified reporting. Not financial advice.

  • Home
  • Submit
  • Earn
  • Sign in
Top storiesRobinhood ChainTech & AIE-commerceWeb3 & CryptoEV & EnergyGlobal & SocialEntertainmentGamingSportsBusiness & marketsHealth & sciencePolitics & worldWhales
Health & science
Important· 57

Australia's Top Medical Body Backs Puberty Blockers for Trans Youth, With Conditions

Australia's National Health and Medical Research Council says puberty blockers are appropriate for transgender children in certain cases. The interim guidelines, out Monday, reject the "wait and see" approach and could pressure states that have banned the treatment. Public consultation runs until January 18.

By the Paparazzi desk Caught by @wahyumaulana
Catcher · Bronze
November 16, 2026 · 3:15 AM · theguardian.com · 0 views
Fact boxTrust 70/100 · Developing
What we verified
  • Original source: theguardian.com.
  • The source published it on Nov 16, 2026 at 3:15 AM.
What we couldn't
  • No second outlet has reported it yet. Treat it as a single-source claim.

Australia's National Health and Medical Research Council has advised that puberty blockers are appropriate for the gender-affirming care of young people in some circumstances. The council released interim national clinical practice guidelines on Monday recommending conditional use of puberty suppressants for under-18s, following a year-long review of international evidence. The advice could push state and territory governments to reconsider their own positions.

The federal government commissioned the review last year in response to bans on the treatment in Queensland and Northern Territory public hospitals. New Zealand's government later followed suit, despite widespread opposition from the health sector and warnings the bans would harm children. The NHMRC explicitly rejected alternatives proposed by opponents of gender-affirming care, including the so-called wait-and-see model, describing it as withholding care that can affect the young person's physical and mental health, wellbeing, and ability to function.

Sponsored

The guidelines do not require a child to be distressed to be treated for gender incongruence. A multi-disciplinary team should be determined on a case-by-case basis, the advice says, and doctors should prioritise the best interest and wellbeing of the young person and provide care that respects their autonomy. Gender incongruence is the clinical term for a difference between a person's gender and their sex recorded at birth, and it is not a mental health disorder, the guidelines state, though some young people with it also experience significant distress known as gender dysphoria.

Puberty blockers stop the body from producing oestrogen and testosterone. They have been used to treat conditions such as precocious puberty since the 1970s, and in gender-affirming care since the 1990s. The NHMRC, an independent statutory agency funded by the commonwealth and one of the world's largest medical research organisations, says its advice is based on its multidisciplinary gender guideline development committee and supported by a systematic review of the evidence. It largely aligns with AusPATH's Australian Standards of Care for Informed Consent Gender-Affirming Hormone Therapy, the country's only existing guidelines for doctors.

Trans and gender diverse young people experience unjust and avoidable health disparities arising from stigma, discrimination, and barriers to accessing health care, the review reads. Public consultation on the interim advice, titled Advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18, runs until January 18. The full guidelines, which will also cover gender-affirming hormones, are expected in 2028.

Price since story
RKLB-4.51%
Market data, not advice.

TopicsNHMRC · AusPATH · Queensland · Northern Territory · New Zealand

Share

Source: theguardian.com

Written by AI from verified reporting. Not financial advice.

More stories

  • Health & science 54 minutes ago · finance.yahoo.com · 0 views
    Novartis' Cosentyx wins FDA nod as first anti-IL-17 biologic for PMR
  • Health & science 3 hours ago · casrai.org · 0 views
    FDA greenlights giredestrant-everolimus duo for ESR1-mutated breast cancer
  • Health & science 4 hours ago · nbcnews.com · Caught by @nina.anggraini29 · 0 views
    Measles Is Endemic Again as the U.S. Loses Its Elimination Status
  • Health & science 4 hours ago · aol.com · 1 view
    FDA Clears FoundationOne Liquid CDx as First Companion Test for WILSERDLY Combo
Catcher tip line

Caught a story we missed?

Log in and send it in. If it checks out, it runs with your name on it and you earn stock tokens. The bigger the story, the bigger the reward.

Submit a story
The newsletter

Get the paper in your inbox.

A short digest of the biggest news, plus optional breaking alerts. Free, no account needed.